Bank of America, the second-largest bank in the United States with roughly 69 million clients, has not been directly hacked in any of the recent incidents that have exposed customer data. That is a ...

Purdue University's online Master's in Data Science will mold the next generation of data science experts and data engineers to help meet unprecedented industry demand for skilled employees. The ...

Abstract: High-fidelity in-phase and quadrature (I/Q) signal traces are critical for a variety of wireless network applications, including spectrum monitoring, interference detection and mitigation, ...

With agentic AI, the database must evolve from a passive ledger to an active reasoning engine that informs, guides, and enables autonomous action. For decades, the database has been the silent partner ...

Artificial intelligence has developed rapidly in recent years, with tech companies investing billions of dollars in data centers to help train and run AI models. The expansion of data centers has ...

Google broke the Pixel IMS app that enabled VoLTE/VoWiFi on unsupported carriers, but the developer has already released a new workaround. Google’s October update patched a loophole that the app ...

INDIANAPOLIS (WISH) — TireRack.com has extended its sponsorship of the Battle on the Bricks IMSA event at Indianapolis Motor Speedway, continuing its role as the “Official Partner” for both the event ...

As of December 31, 2024, a total of 109 patients with R/R MM had received Fucaso, 12.8% had EMD and 11% had received prior BCMA CAR-T therapy. Following lymphodepletion with cyclophosphamide and ...

SHANGHAI, NANJING, China and PLEASANTON, Calif., Sept. 18, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

C4T has completed enrollment and dose escalation for its Phase 1 trial of cemsidomide in MM, which continues to demonstrate a well-tolerated safety profile and compelling response rates. The ...

WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, ...